Purchase Order VA648D95018

The NIH Clinical Center issued a delivery order to Creative Testing Solutions on February 28, 2019, with a ceiling value of $649,776.60 under the Clinical Center's Indefinite Delivery Contract for blood and donor testing services. The parent IDC, valued at $2.96 million and awarded August 1, 2022, procures routine blood and donor testing, infectious disease screening, and specialized serum and blood testing in support of the NIH's transfusion medicine initiatives and research protocols. Place of...

This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Creative Testing Solutions, a non-profit organization, on October 28, 2016. The $144,994.50 contract is to provide routine blood and donor testing services to support the agency's long-term transfusion medicine initiatives and research protocols. The contract has an ultimate completion date of September 20, 2023 and does not have a small business set-aside designation. As the prime...

<p>The National Cancer Institute issued a delivery order to Biomatrix LLC on September 29, 2018, with a ceiling value of $56,492.00, under the Total Small Business set-aside, for tissue source site (TSS) services supporting the Clinical Proteomic Tumor Analysis Consortium (CPTAC).</p> <p>The order covers 50 cases at $467 per case with a 15% adjustment. Place of performance is Rockville, Maryland. The ultimate completion date is September 28, 2020.</p>

The National Institutes of Health National Heart Lung and Blood Institute awarded a $11,250 firm fixed price purchase order to Repeat Diagnostics Inc. to provide telomere flow fluorescence in situ hybridization testing for 45 clinical samples in support of Protocol 17-H-0121. The testing is required to continue patient care, evaluate efficacy and disease progression during the course of drug therapy under the protocol. Repeat Diagnostics will perform the testing at its laboratory located in...

National Medical Services, Inc., doing business as NMS Labs, has been awarded a $199,897 firm fixed price delivery order contract by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to provide neurobiobank tissue toxicology testing services. The contract has no set-aside designation and runs through December 31, 2023. NMS Labs will leverage its expertise in forensic toxicology and drug testing to analyze tissue samples from the...

This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Tasso Inc., a for-profit startup based in Seattle, WA. The contract is for the provision of TASSO SST whole liquid blood self-collection kits to support the VA's Veterans Integrated Service Network 20 in Seattle. The $89,174.30 contract has a completion date of December 31, 2021 and utilizes a firm fixed price pricing structure. Tasso Inc. has received several other VA and...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $57,624 firm fixed price delivery order to Life Technologies Corporation of Carlsbad, California for tissue typing kits. The delivery order was issued against an unspecified governmentwide acquisition contract vehicle and has a completion date of September 30, 2022. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation. The delivery order will provide tissue...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $59,928 firm fixed price delivery order against its single award indefinite-delivery/indefinite-quantity contract for tissue typing kits and related services to Life Technologies Corporation of Carlsbad, California. The delivery order, which has a completion date of September 30, 2023, is for DO OP1 services and will provide tissue typing kits to support the agency's healthcare...

The Defense Health Agency awarded a $102,355.98 firm-fixed-price purchase order to Qualtex Laboratories, a subsidiary of the nonprofit Biobridge Global, to provide testing for transfusion-transmissible diseases in blood samples. The contract, which does not have a set-aside designation, calls for services to be performed in Silver Spring, Maryland, with a completion date of May 26, 2026. Qualtex Laboratories is an experienced federal contractor, having received prior prime contracts from the...

The National Cancer Institute issued a delivery order to Asterand US Acquisition Corporation on June 4, 2019, with a ceiling value of $14,064.05 for tissue source site (TSS) acquisitions supporting the Clinical Proteomic Tumor Analysis Consortium (CPTAC). The delivery order was issued under a Total Small Business set-aside. Place of performance is Detroit, MI. The ultimate completion date was June 3, 2020. The order is priced on a firm fixed price basis and covers tissue purchase order...